Literature DB >> 32317332

Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes.

Lucas Massier1,2, Rima Chakaroun1,2, Shirin Tabei2, Alyce Crane2, Konrad David Didt2, Jörg Fallmann3, Martin von Bergen4, Sven-Bastiaan Haange4, Henrike Heyne2,5,6, Michael Stumvoll1,2, Martin Gericke2,7,8, Arne Dietrich2,9, Matthias Blüher1,2, Niculina Musat10, Peter Kovacs11.   

Abstract

OBJECTIVE: Bacterial translocation to various organs including human adipose tissue (AT) due to increased intestinal permeability remains poorly understood. We hypothesised that: (1) bacterial presence is highly tissue specific and (2) related in composition and quantity to immune inflammatory and metabolic burden.
DESIGN: We quantified and sequenced the bacterial 16S rRNA gene in blood and AT samples (omental, mesenteric and subcutaneous) of 75 subjects with obesity with or without type 2 diabetes (T2D) and used catalysed reporter deposition (CARD) - fluorescence in situ hybridisation (FISH) to detect bacteria in AT.
RESULTS: Under stringent experimental and bioinformatic control for contaminants, bacterial DNA was detected in blood and omental, subcutaneous and mesenteric AT samples in the range of 0.1 to 5 pg/µg DNA isolate. Moreover, CARD-FISH allowed the detection of living, AT-borne bacteria. Proteobacteria and Firmicutes were the predominant phyla, and bacterial quantity was associated with immune cell infiltration, inflammatory and metabolic parameters in a tissue-specific manner. Bacterial composition differed between subjects with and without T2D and was associated with related clinical measures, including systemic and tissues-specific inflammatory markers. Finally, treatment of adipocytes with bacterial DNA in vitro stimulated the expression of TNFA and IL6.
CONCLUSIONS: Our study provides contaminant aware evidence for the presence of bacteria and bacterial DNA in several ATs in obesity and T2D and suggests an important role of bacteria in initiating and sustaining local AT subclinical inflammation and therefore impacting metabolic sequelae of obesity. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  bacterial translocation; inflammation; intestinal permeability; obesity; obesity surgery

Mesh:

Substances:

Year:  2020        PMID: 32317332     DOI: 10.1136/gutjnl-2019-320118

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  Lactobacillus casei Zhang exerts anti-obesity effect to obese glut1 and gut-specific-glut1 knockout mice via gut microbiota modulation mediated different metagenomic pathways.

Authors:  Qiuwen He; Yong Zhang; Da Ma; Weiqin Zhang; Heping Zhang
Journal:  Eur J Nutr       Date:  2022-01-04       Impact factor: 5.614

Review 2.  Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.

Authors:  Herbert Tilg; Timon E Adolph; Michael Dudek; Percy Knolle
Journal:  Nat Metab       Date:  2021-12-20

3.  Keeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance.

Authors:  Darcy E Kahn; Bryan C Bergman
Journal:  Diabetes       Date:  2022-04-01       Impact factor: 9.461

4.  Peripheral and central regulation of insulin by the intestine and microbiome.

Authors:  Jonathan D Schertzer; Tony K T Lam
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-14       Impact factor: 4.310

Review 5.  Emerging concepts in intestinal immune control of obesity-related metabolic disease.

Authors:  Saad Khan; Helen Luck; Shawn Winer; Daniel A Winer
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

6.  Lacticaseibacillus paracasei K56 Attenuates High-Fat Diet-Induced Obesity by Modulating the Gut Microbiota in Mice.

Authors:  Zhonghua Miao; Hanying Zheng; Wei-Hsien Liu; Ruyue Cheng; Hui Lan; Ting Sun; Wen Zhao; Jinxing Li; Xi Shen; Hongwei Li; Haotian Feng; Wei-Lian Hung; Fang He
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-24       Impact factor: 4.609

7.  Fecal Metaproteomics Reveals Reduced Gut Inflammation and Changed Microbial Metabolism Following Lifestyle-Induced Weight Loss.

Authors:  Ronald Biemann; Enrico Buß; Dirk Benndorf; Theresa Lehmann; Kay Schallert; Sebastian Püttker; Udo Reichl; Berend Isermann; Jochen G Schneider; Gunter Saake; Robert Heyer
Journal:  Biomolecules       Date:  2021-05-12

8.  Relationship Between Multidrug-Resistant Enterobacterales and Obesity in Older Adults.

Authors:  Navaneeth Narayanan; Tiffany Lin; David Vinarov; Thomas Bucek; Liya Johnson; Cheryl Mathew; Saira Chaudhry; Luigi Brunetti
Journal:  Infect Drug Resist       Date:  2021-06-30       Impact factor: 4.003

Review 9.  From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators.

Authors:  Hui Han; Bao Yi; Ruqing Zhong; Mengyu Wang; Shunfen Zhang; Jie Ma; Yulong Yin; Jie Yin; Liang Chen; Hongfu Zhang
Journal:  Microbiome       Date:  2021-07-20       Impact factor: 14.650

Review 10.  Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis.

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.